Maarten Kraan appointed Director of Pierre Fabre Pharmaceuticals R&D
The Pierre Fabre Group has announced the appointment of Maarten Kraan to the position of Director of Research and Development for Pierre Fabre Pharmaceuticals (PFM). He will report to Frédéric Duchesne, CEO Pharmaceuticals Division, and will sit on the branch’s Executive Committee.
Since 2016, Maarten Kraan has worked in venture-backed Biotech companies Therachon and Stallergenes Greer.
Maarten Kraan will be responsible for defining and implementing R&D strategy for Pierre Fabre Pharmaceuticals in its three priority areas of innovation: oncology, dermatology and consumer health. Each year, Pierre Fabre Pharmaceuticals allocates approximately 13.5% of its revenues to Research & Development. Its R&D teams are divided between the Pierre Fabre Research Institute (IRPF) based on the Oncopole campus in Toulouse and the Pierre Fabre Immunology Center (CIPF), specialized in monoclonal antibodies, which is based in Saint-Julien-en-Genevois.